Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases

Filippatou AG Moniruzzaman M Sotirchos ES , et al. Serum ceramide levels are altered in multiple sclerosis. Mult Scler 2021; 27(10): 1506–1519.

Park J-W Pewzner-Jung Y. Ceramide synthases: Reexamining longevity. In: Gulbins E Petrache I (eds) Sphingolipids: Basic Science and Drug Development. Vienna: Springer Vienna, 2013, pp. 89–107.

Eberle M Ebel P Mayer CA , et al. Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils. Immunol Cell Biol 2015; 93(9): 825–836.

Kurz J Brunkhorst R Foerch C , et al. The relevance of ceramides and their synthesizing enzymes for multiple sclerosis. Clin Sci (Lond) 2018;132(17):1963–1976.

Checa A Khademi M Sar DG , et al. Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis. Mult Scler 2015; 21(10): 1271–1279.